True Health (Guangdong Hengqin) Medical Technology
AI-powered surgical navigation systems for lung cancer
About True Health (Guangdong Hengqin) Medical Technology
True Health (Guangdong Hengqin) Medical Technology Co., Ltd. is a developer of medical equipment focused on lung cancer treatment. The company was founded in 2018 by Cheong Hou Iam (also known as Zhang Haoren), a Macao resident, and initially established in Beijing before moving its headquarters to the Guangdong-Macao In-Depth Cooperation Zone in Hengqin in August 2023. This strategic relocation was driven by the political and geographical advantages of the Cooperation Zone, which provides a favorable environment for technology companies.
The company develops advanced surgical navigation and robotic systems to enhance the precision and safety of medical procedures. Its product line includes a microwave ablation system with navigation and real-time respiratory tracking, as well as a puncture surgery navigation system. These products utilize artificial intelligence for automatic image analysis, intelligent lesion identification, and puncture path planning. The navigation systems offer an alternative to traditional CT-guided procedures, thereby reducing patients' radiation exposure. By April 2025, True Health's technologies had been implemented in nearly 5,000 surgeries across more than 70 hospitals in mainland China.
True Health operates on a business-to-business model, supplying its high-precision medical devices to top-tier hospitals. The company has secured significant funding to support its growth, including a Series B round in December 2023. Investors include CICC Capital, Huajin Venture Capital, and Korea Investment Partners, among others. The firm has also partnered with the University of Macau and received support from the Science and Technology Development Fund to advance its research and development initiatives.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 15.7/100
- Industry
- Food
- Client focus
- B2C
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Nov 2023 | $14M | $55M | Ligong Chuangdong (Beijing) Investment Management · CICC | ↗ |
Growth signals
Latest recorded traffic for True Health (Guangdong Hengqin) Medical Technology is 2.7K monthly website visits, up 125% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
True Health (Guangdong Hengqin) Medical Technology in the Hueytown ecosystem
The True Health (Guangdong Hengqin) Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- LMLigong Chuangdong (Beijing) Investment Management
CICC
Other known investors1 additional known investor
Castanea Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about True Health (Guangdong Hengqin) Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See True Health (Guangdong Hengqin) Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










